SQZ Biotechnologies (SQZB) to Release Earnings on Wednesday

SQZ Biotechnologies (OTCMKTS:SQZBGet Free Report) is scheduled to issue its quarterly earnings data on Wednesday, March 20th.

SQZ Biotechnologies Price Performance

Shares of OTCMKTS:SQZB opened at $0.05 on Tuesday. The firm has a market cap of $1.37 million, a P/E ratio of -0.02 and a beta of 1.45. The company has a 50 day moving average price of $0.04. SQZ Biotechnologies has a fifty-two week low of $0.01 and a fifty-two week high of $0.82.

About SQZ Biotechnologies

(Get Free Report)

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer.

See Also

Earnings History for SQZ Biotechnologies (OTCMKTS:SQZB)

Receive News & Ratings for SQZ Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQZ Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.